Chemistry and Drug Metabolism Section, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA.
Ther Drug Monit. 2011 Oct;33(5):609-18. doi: 10.1097/FTD.0b013e318228ba39.
Oral fluid collection is noninvasive and easily observed making it an attractive matrix for objectively determining smoking status. Despite large intersubject variability, cotinine oral fluid concentrations correlate with cigarettes smoked per day (CPD). Few studies, however, assessed nicotine markers in oral fluid other than cotinine; other markers might improve smoking status assessment and/or time of last cigarette.
Smoking histories and oral fluid specimens were collected from nontreatment-seeking light (1-10 CPD) and heavy smokers (greater than 10 CPD) and from environmentally exposed and nonexposed nonsmokers who provided written informed consent for this Institutional Review Board-approved study. Nicotine, cotinine, hydroxycotinine (OH-cotinine), and norcotinine oral fluid concentrations were quantified by liquid chromatography tandem mass spectrometry.
Comparison of 1, 3, and 10 ng/mL oral fluid liquid chromatography tandem mass spectrometry cutoffs demonstrated that 10-ng/mL cutoffs performed optimally for cotinine, OH-cotinine, nicotine, and norcotinine identifying 98%, 97%, 88%, and 15% of self-reported smokers; 1% nonsmokers had greater than 10 ng/mL cotinine. No self-reported nonsmoker had greater than 10 ng/mL OH-cotinine, nicotine, or norcotinine. Norcotinine was only identified in smokers' oral fluid. Oral fluid nicotine, cotinine, and nicotine/cotinine ratios were correlated with time of last smoking (r = -0.53, -0.23, and -0.51; P < 0.05) and CPD (r = 0.35, 0.26, and 0.33; P < 0.01), respectively.
OH-cotinine performed slightly better than cotinine for distinguishing smokers from nonsmokers and should be considered as an additional oral fluid smoking indicator. Further research is required to determine if oral fluid norcotinine is a marker for distinguishing light and heavy smokers. Moderate correlations suggest nicotine, cotinine, and nicotine/cotinine ratios may be useful for determining smoking recency in "spot samples" collected during nicotine cessation treatment.
唾液采集无创且易于观察,因此成为客观确定吸烟状况的有吸引力的基质。尽管个体间差异很大,但唾液中的可替宁浓度与每天吸烟的支数(CPD)相关。然而,除了可替宁之外,很少有研究评估唾液中的其他尼古丁标志物;其他标志物可能会改善吸烟状况评估和/或最近吸烟时间。
从非治疗性轻吸烟者(1-10 CPD)和重度吸烟者(大于 10 CPD)以及环境暴露和非暴露的非吸烟者中收集吸烟史和唾液样本,并为这项机构审查委员会批准的研究提供书面知情同意书。通过液相色谱-串联质谱法定量测定尼古丁、可替宁、羟基可替宁(OH-可替宁)和去甲可替宁的唾液浓度。
比较 1、3 和 10ng/mL 唾液液质联用色谱法的截止值表明,10ng/mL 的截止值最适合于可替宁、OH-可替宁、尼古丁和去甲可替宁,可分别识别 98%、97%、88%和 15%的自我报告吸烟者;1%的非吸烟者的可替宁大于 10ng/mL。没有自我报告的非吸烟者的 OH-可替宁、尼古丁或去甲可替宁大于 10ng/mL。仅在吸烟者的唾液中发现去甲可替宁。唾液中的尼古丁、可替宁和尼古丁/可替宁比值与最后吸烟时间(r = -0.53、-0.23 和 -0.51;P < 0.05)和 CPD(r = 0.35、0.26 和 0.33;P < 0.01)呈正相关。
OH-可替宁在区分吸烟者和非吸烟者方面比可替宁略好,应被视为另一种唾液吸烟标志物。需要进一步研究以确定唾液中的去甲可替宁是否是区分轻烟民和重烟民的标志物。中度相关性表明,尼古丁、可替宁和尼古丁/可替宁比值可能有助于确定在尼古丁戒断治疗期间收集的“点样”中最近的吸烟情况。